KTTA logo

Pasithea Therapeutics Corp. Common Stock


KTTA: Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.


Show KTTA Financials

Consumer Interest
SEC Filings

Recent trades of KTTA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by KTTA's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of KTTA in WallStreetBets Daily Discussion


Recent insights relating to KTTA

CNBC Recommendations

Recent picks made for KTTA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in KTTA

Corporate Flights

Flights by private jets registered to KTTA